The specialists of the German biotechnology company Biontech and Pharmaceutical PFizer, together study the new strain of coronavirus discovered in South Africa, more data is expected in two weeks, RIA Novosti reports.
“We expect more data on laboratory research at the last after two weeks,” said the representative of BionTech.
It was emphasized that the data obtained would make it clear whether the new version of Coronavirus B.1.1.529 will require the Pfizer / Biontech vaccine adjustments in the event that it spreads worldwide.